Handelsbanken Fonder’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$500K Sell
10,600
-500
-5% -$23.6K ﹤0.01% 1250
2025
Q1
$434K Hold
11,100
﹤0.01% 1294
2024
Q4
$601K Sell
11,100
-1,900
-15% -$103K ﹤0.01% 1220
2024
Q3
$655K Buy
13,000
+2,700
+26% +$136K ﹤0.01% 1123
2024
Q2
$453K Buy
+10,300
New +$453K ﹤0.01% 1202